Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease

Background. Midkine (MK), a new heparin-binding growth factor, plays important roles in a variety of biological phenomena such as carcinogenesis, inflammation, and angiogenesis. In this study, we aimed to evaluate serum midkine (SMK) and nodular midkine (NMK) levels in patients with thyroid nodules...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzu, Fatih, Arpaci, Dilek, Unal, Mustafa, Altas, Ayfer, Haytaoglu, Gürkan, Can, Murat, Barut, Figen, Kokturk, Furuzan, Ilikhan, Sevil Uygun, Bayraktaroglu, Taner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944023/
https://www.ncbi.nlm.nih.gov/pubmed/27446208
http://dx.doi.org/10.1155/2016/6035024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944023/
https://www.ncbi.nlm.nih.gov/pubmed/27446208
http://dx.doi.org/10.1155/2016/6035024

Ejemplares similares